Exploring key features of selectivity in somatostatin receptors through molecular dynamics simulations

C Guccione1, S Gervasoni1, I Öztürk1

  • 1Department of Physics, University of Cagliari, Monserrato (Cagliari), 09042, Italy.

Insights

This study reveals distinct structural dynamics of somatostatin receptors (SSTRs) and their binding with somatostatin. These findings offer precise guidelines for developing targeted SSTR-based drugs for precision medicine.

Area of Science:

  • Pharmacology
  • Structural Biology
  • Computational Chemistry

Background:

  • Somatostatin receptors (SSTRs) are crucial physiological targets, particularly in oncology, for radiotherapy and radiodiagnosis.
  • Developing selective drugs for the five SSTR isoforms is challenging due to limited structural data.

Purpose of the Study:

  • To computationally analyze the structural and dynamic features of all five SSTR isoforms in complex with somatostatin.
  • To elucidate differences and similarities in receptor dynamics and ligand binding across SSTR isoforms.

Main Methods:

  • Systematic computational analysis of SSTR-SSTR complexes.
  • Utilized experimental structures for SSTR2/SSTR4 and AlphaFold2 models for SSTR1/SSTR3/SSTR5.
  • Performed multi-copy microsecond-long molecular dynamics simulations.

Main Results:

  • Characterized distinct dynamical behaviors and somatostatin binding patterns for each SSTR isoform.
  • Identified a unique extracellular loop 2 conformation in SSTR5, allowing partial closure around somatostatin.
  • Fingerprint analyses revealed specific somatostatin-receptor interaction patterns.

Conclusions:

  • Computational insights into SSTR isoform dynamics and binding are crucial for drug design.
  • Distinct interaction fingerprints provide a basis for developing highly selective somatostatin-based pharmaceuticals.
  • This research supports the advancement of precision medicine therapies targeting SSTRs.

Related Concept Videos

Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.4K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
1.9K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K